medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2016, Number 2

<< Back Next >>

Ann Hepatol 2016; 15 (2)

Good outcomes of liver transplantation for hepatitis C at a low volume centre

Lau SY, Woodman RJ, Silva MF, Muller K, Libby J, Chen JW, Padbury R, Wigg AJ

Language: English
References: 17
Page: 207-214
PDF size: 155.47 Kb.


ABSTRACT

Background and aims. Concerns exist about outcomes of liver transplantation (LT) from low volume centres, especially for hepatitis C (HCV) patients. The aim of the study was to assess patient outcomes as well as their predictors post LT for HCV in a small volume Australian unit (‹ 25 LTs/year), comparing these with the average outcomes obtained from national and international transplant registries. Patients transplanted for HCV at the South Australian Liver Transplant Unit between 1992 and 2012 were studied. Outcomes assessed were patient and graft survival at 1,3, and 5 years. Factors independently associated with the outcomes were assessed using Cox regression model. Results. 1, 3, and 5-year patient survival for HCV patients was 95.2, 82.9, and 78.2%, graft survival were 93.7, 80.1, and 75.5% respectively. The total follow-up time observed was 299.9 years amongst 61 patients in which there were 16 deaths. The expected number of deaths was 40.4 and the standardized mortality ratio 0.40 (95% CI = 0.24, 0.65). These results compared favourably to those obtained from the SRTR registry. Variables independently associated with lower patient survival: donor age (HR = 1.06, 95% CI 1.02 - 1.11; P = 0.003), and post LT cytomegalovirus (CMV) disease requiring treatment (HR = 4.03, 95% CI 1.48 - 10.92;P = 0.06). Conclusion. In conclusion, high rates of patient and graft survival for HCV liver transplantation can be obtained in a small volume unit. Young donor age and lack of CMV disease post-transplant were associated with better outcomes. Institutional factors may be influential determinants of outcomes.


REFERENCES

  1. Lynch SV, Balderson GA. ANZLT Registry Report 2010. Australia and New Zealand Liver Transplant Registry, Brisbane, QLD, Australia.

  2. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ.Liver Transplantation in the United States, 1999-2008. Am J Transpl 2010; 10: 1003-19.

  3. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The Association between Hepatitis C infection and Survival after Orthotopic Liver Transplantation. Gastroenterology 2002; 122: 889-96.

  4. Adam R, Karam V, Delvart V, O’Grady J, Mirza D, Klempnauer J, Castaing D, et al. Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). J Hepatol 2012; 57: 675-88.

  5. Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, et al. The Natural History of Hepatitis C Cirrhosis After Liver Transplantation. Liver Transpl 2009; 15: 1063-71.

  6. Ozhathil DK, Li YF, Smith JK, Tseng JF, Saidi RF, Bozorgzadeh A, Shah SAl. Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl 2011; 17: 1191-9.

  7. Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am J Transpl 2004; 4: 920-7.

  8. Edwards EB, Roberts JP, McBride MA, Schulak JA, Hunsicker LG. The effect of the volume of procedures at transplantation centers on mortality after liver transplantation. N Eng J Med 1999; 341: 2049-53.

  9. Shepherd L, O’Carroll RE, Fergusson E. An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems:a panel study. BMC Med 2014; 12: 131.

  10. Akamatsu N, Sugawara Y. Liver Transplantation and Hepatitis C. Int J Hepatol 2012: 686135. Published online 2012 Jul 26. doi: 10.1155/2012/686135

  11. Burak KW, Kremers WK, Batts KP, Wiesner RH, Rosen CB, Razonable RR, Paya CV, et al. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transplantation 2002;8(4):362-9.

  12. Reese PP, Yeh H, Thomasson AM, Shults J, Markmann JF. Transplant center volume and outcomes after liver retransplantation. Am J Transplant 2009; 9: 309-17.

  13. Kilic A, Weiss ES, Yuh DD, Shah AS, Cameron DE, Baumgartner WA, Conte JV. Institutional factors beyond procedural volume significantly impact center variability in outcomes after orthotopic heart transplantation. Ann Surg 2012; 256: 616-23.

  14. Evaluating the quality of medical care. Milbank Memorial Fund Quarterly 1966; 44: 166-206.

  15. Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and failure to rescue with high-risk surgery.Med Care 2011; 49: 1076-81.

  16. Kan RL, Shamliyan TA, Mueller C, Duval S, Wilt TJ. The association of registered nurse staffing levels and patient outcomes. Med Care 2007; 45: 1195-204.

  17. Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse-staffing levels and the quality of care in hospitals. N Engl J Med 2002; 346: 1715-22.




2020     |     www.medigraphic.com